首页 › 基金 › EVOLVE PRIVATE WEALTH, LLC › UTHR

EVOLVE PRIVATE WEALTH, LLC 对 UTHR 的持仓历史

UNITED THERAPEUTICS CORP DEL · 医疗保健

EVOLVE PRIVATE WEALTH, LLC 在 Q3 2026 的 13F 申报中披露持有 UTHR(UNITED THERAPEUTICS CORP DEL)12,502 股,市值约 US$6.8M,约占其申报组合的 0.32%,在其申报持仓中市值排名第 50 位。 EVOLVE PRIVATE WEALTH, LLC 最近 4 个申报季度中有 4 个季度披露了 UTHR 持仓,最早可追溯至 Q4 2025。

最新持仓 (Q3 2026)12.50K 股
申报持仓市值$6.77M
组合权重0.32%
首次申报Q4 2025
最近变动减持
更新于2026-11-13

最后更新: 2026-11-13 · 来源: SEC EDGAR Form 13F-HR

EVOLVE PRIVATE WEALTH, LLC 对 UTHR 的持仓演变

EVOLVE PRIVATE WEALTH, LLC 于 Q4 2025 首次披露 UTHR 持仓:14,020 股(约 US$6.8M)。 该持仓在 Q1 2026 达到峰值 12,913 股,市值约 US$7.7M。 在 4 次申报中,EVOLVE PRIVATE WEALTH, LLC 0 次增持、3 次减持、0 次保持不变。 最近一期申报(Q3 2026)显示持股 12,502 股、市值约 US$6.8M,环比减持 -233 股。。

逐季持仓明细

季度股数金额变化
Q4 2025 14.02K $6.83M 新进
Q1 2026 12.91K $7.66M 减持
Q2 2026 12.73K $6.90M 减持
Q3 2026 12.50K $6.77M 减持

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 UTHR 与 13F 数据

UTHR(UNITED THERAPEUTICS CORP DEL)属于医疗保健行业。我们追踪的基金中还有 39 只申报持有 UTHR,申报仓位最大的包括:Avoro Capital Advisors LLC (US$1.51B), 文艺复兴科技 (US$908.2M), ASSETMARK, INC (US$325.2M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 UTHR 的基金

查看 UTHR 的全部基金持有人 →

常见问题

How long has EVOLVE PRIVATE WEALTH, LLC held UTHR?

EVOLVE PRIVATE WEALTH, LLC has disclosed UTHR holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is EVOLVE PRIVATE WEALTH, LLC's current position in UTHR?

As of Q3 2026, EVOLVE PRIVATE WEALTH, LLC holds 12.50K shares of UTHR (UNITED THERAPEUTICS CORP DEL), valued at $6.77M, representing 0.32% of its reported portfolio and ranking #50.

Has EVOLVE PRIVATE WEALTH, LLC been buying or selling UTHR?

In the latest 13F filing (Q3 2026), EVOLVE PRIVATE WEALTH, LLC reduced its position in UTHR. The position peaked in Q1 2026 at 12.91K shares.

Which other funds hold UTHR?

Other major institutional holders of UTHR include Avoro Capital Advisors LLC, 文艺复兴科技, ASSETMARK, INC, among 39 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.